TD Cowen Remains a Buy on VYNE Therapeutics (VYNE)
TD Cowen analyst Stacy Ku maintained a Buy rating on VYNE Therapeutics (VYNE – Research Report) today and set a price target of $5.00. The ...
Icon (ICLR) Receives a Buy from TD Cowen
In a report released today, Charles Rhyee from TD Cowen maintained a Buy rating on Icon (ICLR – Research Report), with a price target of ...
Lamar targets $8.13-$8.28 AFFO per share in 2025 with digital expansion and $150M M&A pipeline
AFFO per share guidance for 2025 is projected at $8.13 to $8.28, reflecting growth of 1.8% to 3.6% over 2024. Management anticipates acquisition-adjusted revenue growth of approximately 3%, coupled ...
EPAM Systems (EPAM) Q4 2024 Earnings Call Transcript
Good day and welcome to the fourth quarter and full year 2024 EPAM Systems earnings conference call. All lines have been ...
Evolent Health, Inc. (EVH) Q4 2024 Earnings Call Transcript
Welcome to the Evolent Earnings Conference Call for the Fourth Quarter and Year End December 31, 2024. [Operator Instructions] As a reminder, this conference call is being recorded. Your hosts for the ...
Booking Holdings (BKNG) Q4 2024 Earnings Call Transcript
Welcome to Booking Holdings fourth quarter 2024 conference call. Booking Holdings would like to remind everyone that this ...
MarketWatch21h
Phillips 66
Western Midstream Partners L.P.-0.62% $15.74B ...